TV M80 Pill - brown capsule/oblong
Pill with imprint TV M80 is Brown, Capsule/Oblong and has been identified as Mesalamine Delayed-Release 800 mg. It is supplied by Teva Pharmaceuticals USA, Inc.
Mesalamine is used in the treatment of Ulcerative Colitis, Maintenance; Crohn's Disease, Maintenance; Ulcerative Colitis, Active; Ulcerative Proctitis; Inflammatory Bowel Disease and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 800 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TV M80
![Mesalamine delayed-release 800 mg TV M80](https://www.drugs.com/images/pills/custom/pill36178-1/mesalamine-delayed-release.jpg)
Mesalamine Delayed-Release
- Imprint
- TV M80
- Strength
- 800 mg
- Color
- Brown (reddish brown)
- Shape
- Capsule/Oblong (film-coated, modified capsule-shaped)
- Availability
- Prescription only
- Drug Class
- 5-aminosalicylates
- Pregnancy Category
- B - No proven risk in humans - excluding Asacol and Asacol HD, C - Risk cannot be ruled out - Asacol and Asacol HD
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00480-7750
More about mesalamine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (425)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: 5-aminosalicylates
- Breastfeeding
Patient resources
- Mesalamine drug information
- Mesalamine rectal
- Mesalamine (Oral) (Advanced Reading)
- Mesalamine (Rectal) (Advanced Reading)
- Mesalamine Long-Acting Capsules (Apriso)
Other brands
Pentasa, Lialda, Apriso, Delzicol, ... +4 more
Professional resources
- Mesalamine monograph
- Mesalamine (FDA)
- Mesalamine Capsules (FDA)
- Mesalamine Controlled-Release Capsules (FDA)
- Mesalamine Delayed Release Tablets (FDA)
Other brands
Pentasa, Lialda, Apriso, Asacol, ... +5 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.